Preclinical characterisation of psma/grpr-targeting heterodimer [68ga]ga-bq7812 for pet diagnostic imaging of prostate cancer: a step towards clinical translation

HIGHLIGHTS

  • who: Fanny Lundmark and colleagues from the Department of Medicinal Chemistry, Uppsala University, , Uppsala, Sweden , Saint Petersburg, Russia have published the research work: Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation, in the Journal: Cancers 2023, 442 of 26/02/2021
  • what: As the aim of this study was to bridge the gap between preclinical and clinical use of PSMA/GRPR-heterodimeric radiotracers, toxicology and dosimetry were evaluated. 12 of 15 This study To conclude, the authors have presented the preclinical . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?